DrugPatentWatch Database Preview
Patent: 10,005,783
» See Plans and Pricing
Summary for Patent: 10,005,783
| Title: | Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds |
| Abstract: | Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal. |
| Inventor(s): | Haas; Julia (Boulder, CO), Andrews; Steven W. (Boulder, CO), Jiang; Yutong (Boulder, CO), Zhang; Gan (Boulder, CO) |
| Assignee: | Array BioPharma Inc. (Boulder, CO) |
| Application Number: | 15/399,389 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,005,783
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | HERCEPTIN HYLECTA | trastuzumab; hyaluronidase-oysk | INJECTABLE;SUBCUTANEOUS | 761106 | 001 | 2019-02-28 | Start Trial | Array BioPharma Inc. (Boulder, CO) | 2028-10-22 | RX | search | |
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 002 | 2017-06-22 | Start Trial | Array BioPharma Inc. (Boulder, CO) | 2028-10-22 | RX | Orphan | search |
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 001 | 2017-06-22 | Start Trial | Array BioPharma Inc. (Boulder, CO) | 2028-10-22 | RX | Orphan | search |
| Genentech | KADCYLA | ado-trastuzumab emtansine | VIAL; SINGLE-USE | 125427 | 002 | 2013-02-22 | Start Trial | Array BioPharma Inc. (Boulder, CO) | 2028-10-22 | RX | search | |
| Genentech | KADCYLA | ado-trastuzumab emtansine | VIAL; SINGLE-USE | 125427 | 001 | 2013-02-22 | Start Trial | Array BioPharma Inc. (Boulder, CO) | 2028-10-22 | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Start Trial | Array BioPharma Inc. (Boulder, CO) | 2028-10-22 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 10,005,783
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2010048314 | Start Trial |
| Uruguay | 32192 | Start Trial |
| United States of America | 10047097 | Start Trial |
| United States of America | 2011195948 | Start Trial |
| United States of America | 2014194403 | Start Trial |
| United States of America | 2015005499 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
